Disc Medicine, Inc. prices upsized offering of common stock to raise $225.5 million.

From GlobeNewswire: 2025-01-22 21:35:43

Disc Medicine, Inc. announced the pricing of its upsized underwritten offering of shares of common stock, expecting to raise approximately $225.5 million. The company plans to use the proceeds for research, clinical development, and potential commercialization of bitopertin for hematologic diseases. Jefferies, Leerink Partners, Stifel, and Cantor are acting as joint book-running managers for the offering. The offering is expected to close on January 24, 2025. Interested parties can obtain more information through the SEC’s website or designated contacts. This press release does not constitute an offer to sell securities.



Read more at GlobeNewswire: Disc Medicine Announces Pricing of $225.5 Million Upsized